mTORC1 Promotes T-bet Phosphorylation To Regulate Th1 Differentiation

Olesya Chornoguz(Bloomberg (United States)), Jonathan D. Powell(Enzo Life Sciences (United States)), Christopher Gamper(Johns Hopkins University), Robert S. Hagan(University of North Carolina at Chapel Hill), Arnob Banerjee(Johnson & Johnson (United States)), Matthew L. Arwood(Galen Research (United Kingdom)), Azeb Haile(Johns Hopkins University)

The Journal of Immunology

April 20, 2017

10.4049/jimmunol.1601078

Cited by 47

Related Papers

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

|Biology of Blood and Marrow Transplantation|2008|1.9k

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

|The Lancet|2021|1.7k

Teclistamab in Relapsed or Refractory Multiple Myeloma

|New England Journal of Medicine|2022|1.2k

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2

|Nature Immunology|2011|1.1k

Asymmetric T Lymphocyte Division in the Initiation of Adaptive Immune Responses

|Science|2007|852